GeoVax Announces License Agreement with NIH to Support COVID-19 Vaccine Development
26 oct. 2020 09h00 HE
|
GeoVax, Inc.
ATLANTA, GA, Oct. 26, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (NasdaqCM: GOVX, GOVXW) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and...
Informa Pharma Intelligence Launches New Pulse Report: Clinical Trials & the COVID-19 Vaccine
01 oct. 2020 11h00 HE
|
Informa Business Intelligence
LONDON, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, today released its “Pulse Report: Clinical Trials &...
MEDIA ADVISORY: Expert Commentary and Insight Available on COVID-19 Drug Development
06 août 2020 09h00 HE
|
Tufts Center for the Study of Drug Development
Perspectives on COVID-19 Vaccine and Therapeutic Development from Tufts Center for the Study of Drug Development BOSTON, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Experts from the Tufts Center for the...
ADX Labs捐赠十万美元，用于推进新冠疫苗研发
24 juin 2020 08h08 HE
|
ADX Labs, Inc.
总部位于明尼阿波利斯市的科技企业ADX Labs向流行病防范创新联盟（CEPI）慷慨捐款，CEPI将用此笔善款加速新冠病毒候选疫苗的研发工作。 明尼阿波利斯, June 24, 2020 (GLOBE NEWSWIRE) -- ADX Labs向流行病防范创新联盟（CEPI）捐赠10万美元，用于加速新冠疫苗的研发工作。该善款系通过ADX Labs下属的公益机构ADX基金会提供。 ...
ADX Labs donates $100,000 to advance COVID-19 vaccine research
24 juin 2020 08h08 HE
|
ADX Labs, Inc.
The Coalition for Epidemic Preparedness Innovations (CEPI) is accelerating the development of candidate vaccines against COVID-19 with the financial support of Minneapolis-based technology company ADX...
Informa Pharma Intelligence Announces COVID-19 24-Hour Webinar Series
23 juin 2020 04h46 HE
|
Informa Business Intelligence
LONDON, June 23, 2020 (GLOBE NEWSWIRE) -- Informa Pharma Intelligence, today announces an upcoming free 24-hour interactive webinar series entitled COVID-19 24-hour Web Event: Lessons Learned and a...
Oxford Biomedica Signs Clinical & Commercial Supply Agreement with AstraZeneca, for manufacture of COVID-19 vaccine candidate
28 mai 2020 07h38 HE
|
Oxford BioMedica plc
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of...
COVID-19 and Kawasaki Disease: Low MMR Vaccine Responsiveness Could Be Affecting Children According to World Organization
14 mai 2020 07h02 HE
|
World Organization
ATLANTA, May 14, 2020 (GLOBE NEWSWIRE) -- The report MMR Vaccine Appears to Confer Strong Protection from COVID-19: Few Deaths from SARS-CoV-2 in Highly Vaccinated Populations describes how children...
GeoVax Reports 2020 First Quarter Financial Results and Provides Corporate Update
06 mai 2020 09h00 HE
|
GeoVax, Inc.
Progress on COVID-19 Vaccine Development; Continued Advancements in Other Infectious Disease and Immuno-Oncology Programs ATLANTA, GA, May 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax...
MMR Vaccine Likely Why COVID-19 Rarely Hitting Young According to World Organization
03 mai 2020 07h02 HE
|
World Organization
ATLANTA, May 03, 2020 (GLOBE NEWSWIRE) -- The report MMR Vaccine Link to COVID-19: Fewer Deaths and Milder Cases from SARS-CoV-2 in Measles-Rubella Vaccinated Populations reveals that the MMR...